有氧康复运动治疗慢性心力衰竭的疗效观察

目的 探讨有氧康复运动治疗慢性心力衰竭的疗效及安全性.方法 回顾性分析120例慢性心衰患者的临床资料,在基础药物治疗前提下,根据有无实施有氧康复治疗随机分为2组：A组60例为有氧康复治疗组,B组60例为未实行有氧康复治疗组即对照组.A组患者自入院开始即开始康复运动,心功能Ⅱ级以上者严格按照有氧康复运动方案进行锻炼.比较两组入院及1年后NYHA心功能分级、BNP、LVEF、LVED、6min步行试验距离、再住院率及死亡率.结果 A、B两组组内比较,1年后NYHA心功能分级,BNP、LVEF、LVED均较入院时好转（P＜0.05）.A、B两组组间比较,人院时NYHA心功能分级,BNP、LVEF、LVED差异无统计学意义（P＞0.05）,1年后A组患者明显优于B组患者（P＜0.05）,且6min步行距离较B组明显增加（P＜0.05）,再住院率及死亡率下降（P,＜0.05）.结论 有氧康复运动作为药物治疗的补充,安全有效,适宜慢性心力衰竭患者二级预防治疗.

Clinical observation of aerobic exercise rehabilitation with chronic heart failure

Objective To investigate the efficacy and safety of aerobic exercise rehabilitation in chronic heart failure. Methods A retrospective analysis of 120 patients with chronic heart failure. All the patients were divided into 2 groups according to whether the implementation of aerobic exercise rehabilitation. Group A was the aerobic rehabilitation group with 60 cases. Group B was the control group with 60 cases. Group A patients from admission to start rehabilitation exercise, to the heart function 11 more strictly in ac- cordance with the exercise rehabilitation exercise program with oxygen. The NYHA, BNP, EF, LVED, 6 min- utes walk test distance,rehospitalization rate and mortality were observed from hospital admission to 1 year later. Results After one year,the NYHA, BNP, EF, LVED were better than from admission within A and B groups （P〈0.05）. The NYHA, BNP, EF, LVED had no significant change in A and B groups from ad- mission（P〉0.05）. But the A group was significantly higher than that of B group （P〈0.05） after one year. The 6 minutes walking distance was larger than that of the B group （P〈0.05） and readmission and mortality de- creased （P〈0.05） after 1 year. Conclusion Supplemental aerobic exercise rehabilitation as drug therapy is safe and effective, suitable for secondary prevention therapy in patients with chronic heart failure secondary prevetion.